Reckitt Benckiser Group PLC
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Reckitt Benckiser Group PLC
Bills to reign in petitions, pay-for-delay, product hopping, and patent thickets clear House Judiciary Committee. Legislation may have better shot at enactment this time around given bipartisan support in both House and Senate Committees.
Mead Johnson pulls challenged claims before National Advertising Division began a review in its SWIFT process, but not before Nestlé Nutrition, which markets Gerber infant formula, submitted its challenge.
Advisory board for CRN-operated Supplement OWL recently reached out to industry for “ultimate reason” of recruiting participation. “Transparency has never been more important and this registry is a demonstration of this industry’s commitment to candor and honesty with our regulators, retailers and consumers,” they say.
Settlement proposed in California federal court provides cash refunds of $22 per product, up to three each, to 4.7m claimants. Products identified in complaint include Schiff Move Free Advanced, Moved Free Advanced Plus MSM and Moved Free Advanced Plus MSM & Vitamin D.
- OTC, Consumer